At PANTHERx Rare Pharmacy, our executive team combines years of unique industry experiences to provide excellent partnerships, deliver exceptional care, cultivate extraordinary culture, and set new standards for rare disease pharmacy.

Back to Top

Rob Snyder, PharmD, MBA, CSP

Rob Snyder, PharmD, MBA, CSP

Chief Executive Officer

Dr. Robert Snyder received both his Doctor of Pharmacy degree and his Master of Business Administration from the University of Pittsburgh. At PANTHERx Rare, Dr. Snyder currently serves as the company’s Chief Executive Officer, where he is responsible for maintaining PANTHERx’s sustainable growth and strategic focus, while overseeing all aspects of the business.

Dr. Snyder has experience in specialty pharmacy with a variety of disease states including, Movement Disorders, Cystic Fibrosis, Hepatitis C, Oral Oncology, Nephrology, Enzyme Replacement Therapies, and various other Rare Diseases. Since the launch of PANTHERx in 2011, Dr. Snyder has helped lead the organization through many periods of growth. He has been responsible for a variety of clinical, operational, business development, and Six Sigma projects that continue to provide value to the organization. His unique background and breadth of experience with strategic partners will continue to secure the future of PANTHERx.

Kenneth Bodmer, MBA

Kenneth Bodmer, MBA

Chief Financial Officer

In his current capacity as Chief Financial Officer with PANTHERx Rare Pharmacy, Ken is a strategic member of the management team to inform the company’s expansion and success as a provider of orphan drugs.

During his tenure with CVS Health [formerly Wellpartner], Ken progressed into positions of increasing levels of accountability via exceptional performance. In his final position as VP and General Manager of 340B Services, Ken spearheaded record earnings growth despite a challenging environment in the industry. With Ken at the helm, CVS Health delivered leading 340B third-party administration and contract pharmacy services that resulted in record client savings and double-digit internal expansion in 2020 and 2021. Other positions included serving as Vice President trade finance and CFO & EVP, finance and administration.

For over 20 years, Ken developed his financial and executive leadership presence with Express Scripts [formerly Medco Health Solutions, Inc.]. As an executive leadership team member, Ken managed a growing $450M international division with a presence in the US, EU, and Japan. He led the financial due diligence on two technology acquisitions and championed the development of a five-year strategic plan, as well as operating and financial proposals to support 20% in annual growth. While an executive with Accredo specialty pharmacy, Ken also delivered more than $10M in productivity savings and maintained a 94%+ patient satisfaction rate. In a previous position, he managed a business with more than $16B in annual sales and was part of the team that negotiated a renewal with Medco’s largest client, representing $10B in annual revenue.

Ken completed his Master of Business Administration from Seton Hall University and his Bachelor of Science in Accounting from Villanova University. He is a member of the Financial Executive Institute, the Institute of Management Accountants, the American Institute of CPAs, and the Academy for Healthcare Management.

Richard Faris, Ph.D., R.Ph.

Richard Faris, Ph.D., R.Ph.

Chief Commercial Officer

Richard Faris serves as PANTHERx’s Chief Commercial Officer responsible for pharmacy operations, clinical and patient engagement services, implementation, innovation, and quality.

Prior to joining PANTHERx, Dr. Faris was VP for Clinical Strategy and Services with DaVitaRx. He previously served as Accredo’s Vice President for Clinical Services and Health Outcomes Solutions, and Medco’s/ESI’s National Practice Leader for Rare and Specialty Therapeutics. Dr. Faris served on the executive committees for DaVita Rx and Accredo. He has held leadership positions in health systems, industry, and academia.

Dr. Faris received his Pharmacy degree from the University of Mississippi. He then completed a two-year Masters/residency program with the University of Minnesota and received his Ph.D. from the University of Florida. Dr. Faris has numerous national and international publications, chapters, abstracts, posters, and invited presentations. He recently served as a Board Member for the Pharmacy Quality Alliance.

David Loschinskey

David Loschinskey

Chief Technology Officer

As PANTHERx’s Chief Technology Officer, Dave Loschinskey will oversee our technology teams and support the continued innovation in our PANTHERx Technology Roadmap. All Innovation, Technology, Security and Infrastructure support will be under the guidance of Dave as he propels PANTHERx forward with innovative and competitive solutions to help service our patients, providers, pharmaceutical partners and payers.

Dave brings over 20 years’ specialty pharmacy experience to PANTHERx, across technology and operating roles. Most recently Dave was with Advanced Dermatology and Cosmetic Surgery (ADCS), one of the nation’s leaders in high-quality dermatology, as Executive Vice President of Operations. Dave also founded and ultimately sold 8th Day Software. 8th Day provided software development and supporting services to healthcare companies. Many of 8th Day’s clients were rare disease, specialty pharmacy, infusion, oncology, and genomics companies.

After the sale of 8th Day Software, Dave served as Chief Information Officer and Chief Operations Officer of Diplomat Pharmacy, Inc., once the largest independent provider of specialty pharmacy services in the United States. Dave was responsible for pharmacy operations, call center, clinical teams, education and quality, security, facilities, and the technology teams.

Dave earned his Bachelor of Science in Computer Science from Waynesburg college.

Cheryl Allen, BS Pharm, MBA

Cheryl Allen, BS Pharm, MBA

Chief Growth Officer

Cheryl Allen, Chief Growth Officer, is focused on guiding PANTHERx’s vision by growing our partner relationships and enhancing the organization’s advancement in the industry. Her responsibilities include pharmaceutical business development, payer relationships and marketing.

Cheryl brings more than 25 years of industry experience, with work in independent and specialty pharmacy, as well as in managed care consulting and health care IT. Before joining PANTHERx, Cheryl served as Executive Vice President (EVP) of Business Development at Specialty Pharmacy Nursing Network (SPNN), EVP, Business Development and Industry Relations at Asembia, Principal Consultant at Blue Fin Group, and Vice President of Business Development and Industry Relations at Diplomat. Cheryl also held roles with Sanovia Corporation as Senior Director of Clinical Services, Priority HealthCare as a pharmacist-in-charge for oncology and lead pharmacist for pain management. Cheryl founded C. Allen & Associates, a firm focused on managed care consulting, and Eden Drug Company, an independent specialty pharmacy.

Cheryl earned her Bachelor of Science in pharmacy at Samford University’s McWhorter School of Pharmacy, in Birmingham, Alabama and her MBA at Saint Joseph’s University Erivan K. Haub School of Business with a focus in pharmaceutical and health care marketing in Philadelphia, Pennsylvania.

Timothy Davis Pharm.D.

Timothy Davis Pharm.D.

Special Projects Advisor

Dr. Timothy Davis has been building and expanding patient focused pharmacy practices for almost two decades. His experience includes the construction of clean rooms, compounding laboratories, community pharmacies, pharmacy management software, and adherence technology.

Dr. Davis received his Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy following a Bachelor’s of Science in Neuroscience from the same University. Upon graduation, he launched and operated a small regional chain of independent pharmacies with a focus on emerging practice trends including immunizations, 340B compliance, and automation innovation. Dr. Davis exited the retail pharmacy community to target his efforts on enabling the culture of PANTHERx to develop with the patient at the center of every business and clinical decision opportunity.

Dr. Davis has been featured in numerous industry publications and cover stories concerning his patient focused use of technology, including Pharmacy Times, Pharmacy Today, America’s Pharmacist, and Drug Topics.

Tim Kelly

Tim Kelly

Controller

Tim Kelly joined PANTHERx in November 2017, bringing over 20 years of Finance and Accounting experience, having worked for a Big 4 Accounting firm, publicly traded companies, and a top 25 US based staffing firm. In his previous roles, he has been responsible for consolidating and relocating shared service operations, leading companies through numerous acquisition and integrations, and guiding companies through private equity transactions.

In his role at PANTHERx, Tim is responsible for all financial functions of the company. He recently lead the company’s ERP conversion from QuickBooks to NetSuite. He is skilled in accounting, budgeting, consolidations, negotiating banking relationships, building financial departments, and system implementations.

Tim is a proud life-long resident of Pittsburgh. He graduated from Duquesne University, where he obtained his B.A in Accounting.

Katie DiLorenzo, PharmD

Katie DiLorenzo, PharmD

Vice President, RxARECARE™ Operations

Katie DiLorenzo is Vice President, RxARECARE™ Operations, wherein she is responsible for all operations functions, including RxARECARE™ Teams, Fulfillment Services and Training. All of PANTHERx’s patient facing staff report through Katie’s experienced leadership team. Through PANTHERx’s exponential growth since 2020 and transition to a hybrid work environment, Katie’s team has maintained the highest level of patient satisfaction.

Katie has 12 years of pharmacy experience and has been with PANTHERx for over 7 years, holding various leadership roles within pharmacy operations before being promoted to VP, RxARECARE™ Operations in 2020. Prior to PANTHERx, Katie worked as a Unit-Based Clinical Pharmacist at UPMC Presbyterian specializing in Cardiology.

Katie received her PharmD degree from Duquesne University

Austin Russian, PharmD

Austin Russian, PharmD

Vice President, Program Management

As VP, Program Management, Austin Russian is responsible for the management and ongoing execution of PANTHERx’s pharmaceutical manufacturer accounts. His team manages the relationships for all of our rare disease manufacturers and closely collaborates with all internal teams to ensure partners expectations are exceeded. Austin’s team is integral to the evolution and growth of PANTHERx as a nimble and innovative pharmacy partner.

Austin has 10 years of pharmacy experience, all of which are with PANTHERx. He has held numerous roles including leadership in Operations, Implementation, and Program Management where he has been part of every rare disease launch at PANTHERx.

Austin received his PharmD degree from the University of Pittsburgh

Christina Gabriel

Christina Gabriel

Vice President, Business Development

As Vice President, Business Development, Christina Gabriel is responsible for new business development and market access. She is responsible for identifying, pursuing and maintaining business relationships with manufacturer partners that will complement PANTHERx’s strengths as a Rare Pharmacy. Christina has successfully contracted for over a dozen new RxARECARE programs at PANTHERx since starting in 2019.
Christina has 15 years’ experience in specialty pharmacy, working in various roles before entering trade and business development in 2012. Christina has been with PANTHERx for over 3 years; prior to starting with PANTHERx, Christina worked for Walgreens, most recently as Director, Specialty Pharmacy Accounts.

Christina received her Bachelor of Sciences degree in Actuarial Science from The Pennsylvania State University.